ClassActionLawsuits.biz



 Celebrex - Class Action Information

While no definitive data is currently available that can confirm whether Celebrex may be responsible for deaths, recent studies indicate that Celebrex increases the risk of heart attacks. Celebrex is a Cox-2 inhibitor drug similar to Bextra and Vioxx. Many people are now looking to join class action lawsuits. CTV and Associated Press are reporting that Celebrex class action lawsuits are already being filed against Pfizer in the United States. A Toronto law firm has also launched a $1.5 billion class-action lawsuit against Pfizer on behalf of all Canadians who took Celebrex. The firm McPhadden Samac Merner Darling, which is launching the suit, is claiming that Pfizer misrepresented information about its drug. The lead plaintiff is a Mississauga, Ontario woman who claims she lost earnings after developing an irregular heartbeat and cardiovascular problems after taking Celebrex.

Return to Main



 ClassActionLawsuits.biz














copyright © 2005 ClassActionLawsuits.biz